$ADGM News
Last published 1d ago
- 1d agoADGMAdagio Medical Provides Business Update: 22 Patients Treated with Next-Generation vCLAS™ Ultra System as FULCRUM-VT IDE Sub-Study AdvancesBusiness WireLAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today provided a business update highlighting continued execution of its FULCRUM-VT IDE study and FULCRUM-VT IDE sub-study, as well as progress of its previously announced review of strategic ...
- 5d agoADGMTrading halt: Adagio Medical Holdings Inc CS (ADGM), News pendingNasdaq Trading HaltsHalted 2026-11-06 19:50:00.000 ET, resumption quote none, resumption trade none.
- 1mo agoADGMAdagio Medical Announces Strategic Review Process to Maximize Shareholder ValueBusiness WireCompany Continues to Advance PMA Application for vCLAS Ventricular Ablation System While Board Evaluates Full Range of Strategic Options Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the
- 1mo agoADGMAdagio Medical Highlights First Patient Treated in IDE Study Evaluating Next-Generation vCLAS™ Ultra System for Ventricular Tachycardia at Banner – University Medical Center PhoenixBusiness WireEnrollment Underway Across Multiple Sites as Study Advances Faster, Improved ULTA Catheter for the Broadest Population of VT Patients Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the
- 2mo agoTFXMDTADGMTeleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of DirectorsBusiness WireTeleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors, effective September 8, 2026. Mr. Salmon brings over
- 3mo agoADGMAdagio Medical Reports Second Quarter 2026 ResultsBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results
- 3mo agoADGMAdagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA SystemBusiness WirevCLAS Ultra System Designed to Optimize Usability and Workstream to Address Entire Spectrum of Ventricular Tachycardia PatientsAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a
- 5mo agoADGMAdagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular TachycardiaBusiness WirePMA Submission Supported by FULCRUM-VT Pivotal Trial Data — 209 Patients Across 20 Leading Centers; Breakthrough Device Designation Previously Granted Marks the First-Ever PMA Submission for a Purpose-Built VT
- 6mo agoADGMAdagio Medical Reports First Quarter 2026 Results and Meaningful Clinical ProgressBusiness WireAdvancing Toward Submission for PMA Approval Following Late-Breaking FULCRUM-VT Data Adagio Medical Holdings, Inc (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for
- 6mo agoADGMAdagio Medical to Participate in the BofA Securities 2026 Health Care ConferenceBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting
- 6mo agoADGMAdagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation SystemBusiness Wire84% Freedom From Shock and 59% Freedom From VT Recurrence in FULCRUM-VT Pivotal IDE Trial Meet Safety and Effectiveness Endpoints and Replicate CryoCure-VT Results First and Only Ablation Technology to Show Equivalent
- 6mo agoADGMAdagio Medical's ULTA Technology to Be Featured at the Heart Rhythm 2026 ConferenceBusiness WireUse of ULTA Across Broad Spectrum of Ventricular Tachycardias to be Highlighted in Multiple Scientific Presentations, Including Late-Breaking Clinical Trial Session Adagio Medical Holdings, Inc. (NASDAQ:ADGM)
- 7mo agoADGMAdagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation SystemBusiness WireDesigned to Deliver Faster, More Efficient Ablation with Improved Usability on Established, Titratable, Endocardial-Approach ULTA Platform Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a
- 7mo agoADGMAdagio Medical to Participate in the 25th Annual Needham Virtual ConferenceBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be
- 7mo agoADGMAdagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026Business WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the pivotal results from the
- 7mo agoADGMAdagio Medical Reports Fourth Quarter and Full Year 2025 ResultsBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the fourth
- 7mo agoADGMAdagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation CatheterBusiness WireHighlights Improvements in Next Generation ULTA Catheter, Including Potential 50-75% Reduction in Ablation Time Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter
- 7mo agoADGMAdagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)Business WirevCLASTM Used to Treat Patients with No Satisfactory Approved Treatment and/or Failed RF or PFA Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation
- 8mo agoADGMAdagio Medical to Participate in the 38th Annual Roth ConferenceBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be
- 8mo agoADGMAdagio Medical to Participate in the TD Cowen 46th Annual Healthcare ConferenceBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting
- 9mo agoADGMAUUAFBCCEFBTLRF+7Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand ViewingGlobeNewswireNEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Small Cap Growth Virtual Investor Conference,
- 9mo agoADGMNew Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular TachycardiaBusiness WireEarly Feasibility Outcomes in a Real-World Patient Cohort of Both Ischemic and Challenging Non-Ischemic Patients Published in Circulation: Arrhythmia and Electrophysiology Adagio Medical Holdings, Inc (NASDAQ:ADGM)
- 9mo agoADGMAUUAFBCCEFBTLRF+6Small Cap Growth Virtual Investor Conference Agenda Announced for February 5thGlobeNewswireNEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for the Small Cap Growth Virtual Investor Conference to be held
- 9mo agoADGMAdagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be
- 9mo agoADGMAdagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5thGlobeNewswireLAGUNA HILLS, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Adagio Medical Holdings, Inc. (NASDAQ:ADGM), based in Laguna Hills, CA, a leading innovator in catheter ablation technologies for the treatment of cardiac
- 10mo agoADGMAdagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial ReadinessBusiness WireMarie-Claude Jacques appointed Senior Vice President, Global Sales; Antwan Gipson joins as Senior Vice President, Manufacturing & Operations Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"),
- 11mo agoADGMAdagio Medical Appoints Industry Veteran Sean Salmon to Board of DirectorsBusiness WireAdagio Medical Holdings, Inc (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean Salmon has been appointed
- 12mo agoADGMAdagio Medical Reports Third Quarter 2025 ResultsBusiness WireContinued Momentum Toward PMA Submission of ULTC Technologies Recent Financing Positions Company to Execute Growth Strategy Adagio Medical Holdings, Inc (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator
- 1y agoADGMAdagio Medical to Present at the Piper Sandler 37th Annual Healthcare ConferenceBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting
- 1y agoADGMAdagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular TachycardiaBusiness WireProceeds Expected to Fund Ongoing Development and Submission Activities to Support FDA Evaluation of Company's First and Next Generation Proprietary Ultralow Cryoablation Technologies Adagio Medical Holdings, Inc.
- 1y agoADGMAdagio Medical Announces Pricing of up to $50 Million Private Placement of SecuritiesBusiness WireFinancing to Provide Approximately $19 Million in Upfront Proceeds Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or the "Company"), a leading innovator in catheter ablation technologies for the treatment of
- 1y agoADGMAdagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT SymposiumBusiness Wire97% Acute Effectiveness and Favorable Safety Results from Proprietary ULTC for Ventricular Tachycardia Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation
- 1y agoADGMAdagio Medical Expands Chief Business Officer Deborah Kaster's Role to Include Chief Financial Officer ResponsibilitiesBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the Company's Chief Business
- 1y agoADGMAdagio Medical Reports Second Quarter 2025 ResultsBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the second
- 1y agoADGMAdagio Medical Reports First Quarter 2025 ResultsBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the first
- 1y agoADGMAdagio Medical to Present at the BofA Securities 2025 Health Care ConferenceBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management will be presenting
- 1y agoADGMAdagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation SystemBusiness WireAgency's Breakthrough Device Designation Program Allows for Priority Review of Ablation Technology for Ventricular Tachycardia Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a leading
- 1y agoADGMAdagio Medical Appoints Deborah Kaster as Chief Business OfficerBusiness WireAdagio Medical (NASDAQ:ADGM), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, is pleased to announce the appointment of Deborah Kaster as Chief Business Officer (CBO). Kaster
- 1y agoADGMAdagio Medical Reports Fourth Quarter and Full Year 2024 ResultsBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported financial results for the fourth quarter and full year ended
- 1y agoADGMAdagio Medical Provides Clinical and Business UpdatesBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM, the "Company")), a leading innovator in catheter ablation technologies, provided updates today on the progress in its streamlined focus on leadership in ventricular
- 1y agoADGMAdagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product InnovationBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM, the "Company")), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced a corporate restructuring and realignment of
- 1y agoADGMAdagio Medical to Participate at the TD Cowen's 45th Annual Health Care ConferenceBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM, the "Company")), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced that management will be attending TD Cowen's
- 1y agoADGMAdagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and DirectorBusiness WireFounding Chief Executive Officer and Director Olav Bergheim to Depart Adagio Medical Holdings, Inc. (NASDAQ:ADGM, the "Company" or "Adagio")), a leading innovator in catheter ablation technologies for treatment of
- 1y agoADGMAdagio Medical Reports Third Quarter 2024 ResultsBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM, the "Company" or "Adagio")), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced, today provided business updates for
- 2y agoADGMAdagio Medical to Present at the Stifel 2024 Healthcare ConferenceBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM, the "Company")), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced that its CEO & President, Olav Bergheim, will
- 2y agoADGMAdagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation SystemBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM, "Adagio Medical", "Adagio" or the "Company")), a leading innovator in catheter ablation technologies, today announced the completion of the first procedures in FULCRUM-VT U.S.
- 2y agoADGMAdagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular ArrhythmiasBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM, the "Company")), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced its sponsorship and participation in the 19th
- 2y agoADGMARYDAdagio Medical Provides Business UpdatesBusiness WireAdagio Medical Holdings, Inc. (NASDAQ:ADGM, the "Company")), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today provided a business update. Recent Business